• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HE Xiaomeng,YANG Yong,CHEN Zhen.Research progress of FcγRs on the develepment and treatment of immune disease[J].Journal Of Pharmaceutical Research,2017,36(1):32-35[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4272times   Download 3377次 QR Code for this article
Scan with your phone!
FcγRs与免疫相关疾病发生发展及其治疗研究进展
贺肖梦1,杨勇2,陈真1
Font:Larger+|Default|Smaller-
(1.中国药科大学药学医学基础实验教学中心,江苏 南京 211198;2.中国药科大学药物科学研究院,江苏 南京 211198)
摘要:
Fcγ受体(Fcγ receptors,FcγRs)是白细胞免疫球蛋白G(Immunoglobulin G,IgG)受体,对特异性IgG具有强大的效应功能,起着连接机体体液免疫和细胞免疫的桥梁作用。FcγRs可通过与IgG特定区域结合,引起相应的细胞特异性免疫反应。FcγRs的基因多态性,使其能引起多样的细胞内生物效应,而这又与多种免疫相关疾病的发生发展密切相关。研究表明,FcγRs影响单克隆抗体(Monoclonal Antibody,mAb)和静脉注射免疫球蛋白(Intravenous Immunoglobulins, IVIg)免疫治疗疗效。另有研究显示,FcγR在微生物感染疾病中也发挥一定作用。本文通过综述FcγRs及其与多种疾病的相关性,深入探讨了其临床诊疗意义。
关键词:  FcγRs  免疫  免疫相关疾病  免疫治疗
DOI:10.13506/j.cnki.jpr.2017.01.010
基金项目:国家自然科学基金(No.81473230、No.91129731)
Research progress of FcγRs on the develepment and treatment of immune disease
HE Xiaomeng1,YANG Yong2,CHEN Zhen1
(1.Pharmaceutical and Medical Basic Experiment Teaching Center,China Pharmaceutical University,Nanjing 211198,China;2.Drug Research Institute,China Pharmaceutical University,Nanjing 211198,China)
Abstract:
Leukocyte immunoglobulin G receptors (FcγR) belong to the immunoglobulin superfamily,have potent effector functions to the specificity of IgG,and serve as a link between the humoral and cellular immunity.The specific region of IgG binding to FcγRwill induce a series of cell specific immunoreaction. Furthermore,FcγR polymorphisms influence the efficacy of cellular responses,and have been associated withimmunity relateddiseases and diseases severity.Studies also suggest that FcγRs influence effectiveness of immunotherapy (monoclonal antibody and intravenous immunoglobulins).Similarly,FcγRs play a role in the microbial infections.This review will summarize the relationship of FcγRsand immunological diseases,and discuss its potential clinical relevance.
Key words:  FcγRs  Immunity  Immunity related diseases  Immunotherapy
Today's Visits:464    Total Visits:2383159
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.